Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Synthetic strategies toward structurally diverse seven-membered ε-sultams: a review.

Created on 23 Sep 2026

Authors

Koushik Naskar, Sudip Karmakar, Imtiaj Mondal, Indubhusan Deb

Published in

Chemical communications (Cambridge, England). Sep 23, 2026. Epub Sep 23, 2026.

Abstract

Seven-membered (di)benzo-ε-sultams represent an important class of cyclic sulfonamide-containing heterocycles with significant potential in medicinal chemistry and chemical biology. Recent years have witnessed substantial progress in their synthesis through organocatalytic, transition-metal-catalyzed, photochemical, electrochemical and several other approaches, enabling access to structurally diverse and enantioenriched frameworks. Key developments include asymmetric aza-Friedel-Crafts reactions, nucleophilic additions, Mannich reactions, annulation reactions and ring-expansion strategies. Despite these advances, (di)benzo-ε-sultams remain relatively underexplored, with challenges in substrate scope, three-dimensional structural complexity, and mechanistic understanding. Therefore, this review highlights the existing synthetic methodologies, mechanistic insights, stereochemical approaches, and their outcomes. It aims to inspire further research toward the synthesis of diverse ε-sultams through the development of general and sustainable strategies building on the rich chemistry of acyclic and cyclic imines.

PMID:
42775435
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement